RecruitingNot ApplicableNCT05290610
Intracranial Stimulation Mapping In Epilepsy
Intracranial Stimulation Mapping In Epilepsy -The InStim Study
Sponsor
University of Minnesota
Enrollment
30 participants
Start Date
Jun 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This is a single group prospective study to determine the feasibility for generating brain maps that localize cerebral functions and inter-regional information flow in partial epilepsy in adult patients.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Male or female 18 years and older at screening.
- Written informed consent is obtained from the participant to comply with the requirements of the study.
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Currently undergoing clinically indicated intracranial EEG monitoring for planning of epilepsy surgery in the University of Minnesota/MINCEP program.
Exclusion Criteria2
- Pregnancy ruled out prior to approval for intracranial EG monitoring.
- Persons who are rendered temporarily or permanently invulnerable by inability to understand the research due to study complexity, cognitive impairment, or by inability to make independent decisions owing to University of Minnesota or to Fairview health services.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERFunctional mapping
Intracranial EEG data acquisition, observation and behavioral testing, and intracranial electrical stimulation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05290610
Related Trials
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
NCT021079891 location
Tumor Related Epilepsy
NCT026393251 location
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
NCT025318801 location
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
NCT075638813 locations
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
NCT0705162910 locations